西藏利众院：扎根高原，以创新驱动中藏药产业发展

Core Insights - The article highlights the growth and development of Tibet Lizhongyuan Biotechnology Co., Ltd. as a leading player in the traditional Tibetan medicine industry, supported by Kunming Pharmaceutical Group since 2010 [1][2]. Group 1: Resource Integration - Tibet Lizhongyuan has established a robust capital and technical support system, with Kunming Pharmaceutical Group holding a 75% stake, allowing for effective integration of high-quality medicinal resources and modern production technologies [2]. - The company has built a complete industry chain from medicinal material cultivation to processing and distribution, benefiting from a favorable corporate tax rate of 15% in Tibet, which helps reduce operational costs [2]. Group 2: Diversified Development - The company has expanded its business into various sectors, including traditional Tibetan medicine, antibiotics, biopharmaceuticals, health products, cosmetics, and beverages, showcasing a diversified development strategy [3]. - Tibet Lizhongyuan is also exploring emerging fields such as ecological tourism and agricultural product trade, enhancing its industry structure and market presence [3]. Group 3: Financial Performance - Financial data indicates that Tibet Lizhongyuan has maintained steady growth, with a revenue of 297 million yuan and a net profit of 3.459 million yuan in the first half of 2019, alongside stable cash flow exceeding 30 million yuan [4]. - As of 2023, the company's asset scale has surpassed 38 million yuan, positioning it as a benchmark enterprise in the Tibetan pharmaceutical sector [4]. Group 4: Heritage and Innovation - The company emphasizes the integration of traditional Tibetan medicine wisdom with modern technology, aiming to create an internationally influential ethnic medicine brand [5]. - Through continuous technological innovation and product upgrades, Tibet Lizhongyuan has launched a series of proprietary Tibetan medicine products, gaining widespread market recognition [5]. - Looking ahead, the company plans to leverage its resource advantages and deepen collaboration with Kunming Pharmaceutical Group to promote high-quality development in the Tibetan medicine industry [5].